Headache and epilepsy topical collection on secondary headache

Current Pain and Headache Reports

Volumn 17, Issue 8, 2013, Pages

  Bauer, P R ^a   Carpay, J A ^b   Terwindt, G M ^b   Sander, J W ^a,c,d   Thijs, R J ^a,b   Haan, J ^b,e   Visser, G H ^a  

^a STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d EPILEPSY SOCIETY   (United Kingdom)

^e RIJNLAND HOSPITAL   (Netherlands)

Author keywords

Cortical excitability; Cortical spreading depolarisation; Cortical spreading depression; Epilepsy; Familial hemiplegic migraine; Headache; Ictal headache; Migraine; Migralepsy; Peri ictal headache; Post ictal headache

Indexed keywords

4 AMINOBUTYRIC ACID; SCN1A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.1;

ARTICLE; ATPA1A GENE; CACNA1A GENE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; EPILEPSY; EPILEPTOGENESIS; FAMILIAL HEMIPLEGIC MIGRAINE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; HEADACHE; HEMICRANIA EPILEPTICA; HUMAN; ICTAL HEADACHE; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDER II; MIGRAINE AURA; MIGRAINE WITH AURA; MIGRALEPSY; MUTATIONAL ANALYSIS; MYOCLONUS EPILEPSY; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PERIICTAL HEADACHE; PREVALENCE; PRIMARY HEADACHE; PRRT2 GENE; SCN1A GENE; SPREADING CORTICAL DEPRESSION; SUBARACHNOID HEMORRHAGE; BRAIN CIRCULATION; FEMALE; GENETICS; MALE; MIGRAINE DISORDERS; MUTATION; SEIZURES;

CEREBROVASCULAR CIRCULATION; COMORBIDITY; CORTICAL SPREADING DEPRESSION; EPILEPSY; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIGRAINE DISORDERS; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; SEIZURES;

EID: 84893499191     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0351-x     Document Type: Article

References (79)

1. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193-210.
2. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013. doi: 10.111/head.12074.
3. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 2000;123:665-76.
4. Forsgren L, Beghi E, Oun A, Sillanpää M. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol. 2005;12(4):245-53.
5. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol. 2003;16(2):165-70.
6. Kwan P, Man CBL, Leung H, et al. Headache in patients with epilepsy: a prospective incidence study. Epilepsia. 2008;49(6):1099-102.
7. Syvertsen M, Helde G, Stovner LJ, Brodtkorb E. Headaches add to the burden of epilepsy. J Headache Pain. 2007;8(4):224-30.
8. Ito M, Adachi N, Nakamura F, et al. Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia. 2004;24(1):23-8.
9. Nunes JC, Zakon DB, Claudino LS, et al. Headache among mesial temporal lobe epilepsy patients: a case-control study. J Neurol Sci. 2011;306(1-2):20-3.
10. Yankovsky AE, Andermann F, Bernasconi A. Characteristics of headache associated with intractable partial epilepsy. Epilepsia. 2005;46(8):1241-5.
11. Ottman R, Lipton RB, Ettinger AB, et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia. 2011;52(2):308-15.
12. Téllez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia. 2005;46(12):1955-62.
13. Le H, Tfelt-Hansen P, Russell MB, et al. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia. 2011;31(1):43-64.
14. Brodtkorb E, Bakken IJ, Sjaastad O. Comorbidity of migraine and epilepsy in a Norwegian community. Eur J Neurol. 2008;15(12):1421-3.
15. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428-32.
16. Chen Y-C, Tang C-H, Ng K, Wang S-J. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain. 2012;13(4):311-9.
17. Lateef TM, Cui L, Nelson KB, et al. Physical comorbidity of migraine and other headaches in US adolescents. J Pediatr. 2012;161(2):308-13.
18. Olesen J. The international classification of headache disorders. Headache. 2004;24(s1):1-150.
19. Kelley SA, Hartman AL, Kossoff EH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 2012;79(5):468-73.
20. Schankin CJ, Rémi J, Klaus I, et al. Headache in juvenile myoclonic epilepsy. J Headache Pain. 2011;12(2):227-33.
21. Baldin E, Ludvigsson P, Mixa O, Hesdorffer DC. Prevalence of recurrent symptoms and their association with epilepsy and febrile seizure in school-aged children: a community-based survey in Iceland. Epilepsy Behav. 2012;23(3):315-9.
22. Duchaczek B, Ghaeni L, Matzen J, Holtkamp M. Interictal and periictal headache in patients with epilepsy. Eur J Neurol. 2012;25:1-7.
23. Tonini MC, Giordano L, Atzeni L, et al. Primary headache and epilepsy: a multicenter cross-sectional study. Epilepsy Behav. 2012;23(3):342-7.
24. Winawer MR, Connors R. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia. 2013. doi: 10.1111/epi.12072.
25. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.
26. Verrotti A, Striano P, Belcastro V, et al. Migralepsy and related conditions: advances in pathophysiology and classification. Seizure. 2011;20(4):271-5.
27. Sances G, Guaschino E, Perucca P. Migralepsy: a call for a revision of the definition. Epilepsia. 2009;50(11):2487-96.
28. Belcastro V, Striano P, Villa MP, Parisi P. Migralepsy, hemicrania epileptica, post-ictal headache and "ictal epileptic headache": a proposal for terminology and classification revision. J Headache Pain. 2011;12(3):289-94.
29. Parisi P, Striano P, Kasteleijn-Nolst Trenité DGA, et al. "Ictal epileptic headache": recent concepts for new classifications criteria. Cephalalgia. 2012;32(9):723-4.
30. Dainese F, Mai R, Francione S, et al. Ictal headache: headache as first ictal symptom in focal epilepsy. Epilepsy Behav. 2011;22(4):790-2.
31. Fanella M, Fattouch J, Casciato S, et al. Ictal epileptic headache as "subtle" symptom in generalized idiopathic epilepsy. Epilepsia. 2012;53(4):e67-70.
32. • Adcock JE, Panayiotopoulos CP. Occipital lobe seizures and epilepsies. J Clin Neurophysiol. 2012;29(5):397-407. This review gives a very complete overview of occipital lobe seizures.
33. Haan J, Terwindt GM, Van den Maagdenberg AMJM, et al. A review of the genetic relation between migraine and epilepsy. Cephalalgia. 2008;28(2):105-13.
34. Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010;42(10):869-73.
35. De Vries B, Frants RR, Ferrari MD, Van den Maagdenberg AMJM. Molecular genetics of migraine. Hum Genet. 2009;126(1):115-32.
36. Freilinger T, Anttila V, De Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet. 2012;44(7):777-82.
37. Tan NCK, Berkovic SF. The Epilepsy Genetic Association Database (epiGAD): analysis of 165 genetic association studies, 1996-2008. Epilepsia. 2010;51(4):686-9.
38. Frosk P, Mhanni AA, Rafay MF. SCNIA mutation associated with intractable myoclonic epilepsy and migraine headache. J Child Neurol. 2012. doi: 10.1177/0883073812443309. 1-4.
39. Magis D, Boon E, Coppola G, et al. A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache. Cephalalgia. 2012;32(15):1147-9.
40. Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology. 2012;79(21):2109-14.
41. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79(21):2115-21.
42. Méneret A, Gaudebout C, Riant F, et al. PRRT2 mutations and paroxysmal disorders. Eur J Neurol. 2013. doi: 10.1111/ene.12104.
43. Polvi A, Siren A, Kallela M, et al. Shared loci for migraine and epilepsy on chromosomes 14q12-q23 and 12q24.2-q24.3. Neurology. 2012;78(3):202-9.
44. Somjen GG. Ion regulation in the brain: implications for pathophysiology. Neuroscientist. 2002;8:254-67.
45. Coppola G, Schoenen J. Cortical excitability in chronic migraine. Curr Pain Headache Rep. 2012;16(1):93-100.
46. Badawy RAB, Harvey AS, Macdonell RAL. Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1. J Clin Neurosci. 2009;16(3):355-65.
47. Garza-López E, Sandoval A, González-Ramírez R, et al. Familial hemiplegic migraine type 1 mutations W1684R and V1696I alter G protein-mediated regulation of Ca(V)2.1 voltage-gated calcium channels. Biochim Biophys Acta. 2012;1822(8):1238-46.
48. Badawy RAB, Curatolo JM, Newton M, et al. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol. 2007;61(4):324-31.
49. Mulleners WM, Chronicle EP, Palmer JE, et al. Visual cortex excitability in migraine with and without aura. Headache. 2001;41(6):565-72.
50. Van Der Kamp W, Maassenvandenbrink A, Ferrari MD, Van Dijk G. Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine. Neurology. 1997;1:1996-8.
51. •• Badawy RAB, Jackson GD. Cortical excitability in migraine and epilepsy: a common feature? J Clin Neurophysiol. 2012;29(3):244-9. This is, to our knowledge, the first study to directly compare cortical excitability in epilepsy and migraine.
52. Merlo D, Mollinari C, Inaba Y, et al. Reduced GABAB receptor subunit expression and paired-pulse depression in a genetic model of absence seizures. Neurobiol Dis. 2007;25(3):631-41.
53. Mathew J, Balakrishnan S, Antony S, et al. Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A. J Biomed Sci. 2012;19(1):25.
54. Brown JT, Gill CH, Farmer CE, et al. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABA B1 receptor subunit knockout mice. Epilepsy Res. 2003;57(2-3):121-36.
55. Holland PR, Akerman S, Goadsby PJ. Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia. 2010;30(5):519-27.
56. Plummer PN, Colson NJ, Lewohl JM, et al. Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs. Gene. 2011;490(1-2):32-6.
57. Russo L, Mariotti P, Sangiorgi E, et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet. 2005;76(2):327-33.
58. Oswell G, Kaunisto MA, Kallela M, et al. No association of migraine to the GABA-A receptor complex on chromosome 15. Am J Med Genet. 2008;147B(1):33-6.
59. Netzer C, Freudenberg J, Toliat MR, et al. Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with aura. Am J Med Genet. 2008;147B(1):37-41.
60. Fernandez F, Esposito T, Lea RA, et al. Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility. BMC Med Genet. 2008;9:109.
61. Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet. 2001;28(1):49-52.
62. Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet. 2001;28(1):46-8.
63. Lachance-Touchette P, Brown P, Meloche C, et al. Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. Eur J Neurosci. 2011;34(2):237-49.
64. Lauritzen M, Dreier JP, Fabricius M. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31(1):17-35.
65. • Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17(4):439-47. This review addresses the complex issue of spreading depolarization and gives an overview of the current understanding of this phenomenon in relation to neurologic conditions.
66. Herreras O, Largo C, Ibarz JM, et al. Role of neuronal synchronizing mechanisms in the propagation of spreading depression in the in vivo hippocampus. J Neurosci. 1994;14(11):7087-98.
67. Larrosa B, Pastor J, López-Aguado L, Herreras O. A role for glutamate and glia in the fast network oscillations preceding spreading depression. Neuroscience. 2006;141(2):1057-68.
68. Mayevsky A, Doron A, Manor T, et al. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system. Brain Res. 1996;740(1-2):268-74.
69. Strong AJ, Fabricius M, Boutelle MG, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke. 2002;33(12):2738-43.
70. Fabricius M, Fuhr S, Bhatia R, et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain. 2006;129:778-90.
71. •• Dreier JP, Major S, Pannek H-W, et al. Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain. 2012;135:259-75. This study demonstrates spreading convulsions for the first time in humans, and links cortical spreading depression to later occurrence of epilepsy.
72. Tomkins O, Friedman O, Ivens S, et al. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis. 2007;25(2):367-77.
73. Fabricius M, Fuhr S, Willumsen L, et al. Association of seizures with cortical spreading depression and peri-infarct depolarisations in the acutely injured human brain. Clin Neurophysiol. 2009;119(9):1973-84.
74. Gorji A, Speckmann E. Spreading depression enhances the spontaneous epileptiform activity in human neocortical tissues. Eur J Neurosci. 2004;19:3371-4.
75. Krüger H, Luhmann HJ, Heinemann U. Repetitive spreading depression causes selective suppression of GABAergic function. NeuroReport. 1996;7:2733-6.
76. Maslarova A, Alam M, Reiffurth C, et al. Chronically epileptic human and rat neocortex display a similar resistance against spreading depolarization in vitro. Stroke. 2011;42(10):2917-22.
77. Van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41(5):701-10.
78. •• Van den Maagdenberg AMJM, Pizzorusso T, Kaja S, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol. 2010;67(1):85-98. This study demonstrates that a CACNA1A mutation in mice can lead to a higher susceptibility for cortical spreading depresion.
79. Dreier JP, Sakowitz OW, Unterberg AW, et al. Migrainous aura starting several minutes after the onset of subarachnoid hemorrhage. Neurology. 2001;57(7):1344-5.